In order to investigate the effects of anlotinib on inflammatory factors within xenograft tumors, we examined the expression of IL-6, IL-8 and VEGFA in tumor tissues of four treatment groups by immunofluorescence staining. This evidence concerns the gene IL6 and neoplasm.